Literature DB >> 10532249

Postmenopausal hormone therapy, SERMs, and coronary heart disease in women.

N K Wenger1, D Grady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10532249     DOI： 10.1007/BF03343619

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  55 in total

Review 1.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

2.  Hormone replacement therapy, heart disease, and other considerations.

Authors:  E Barrett-Connor; D Grady
Journal:  Annu Rev Public Health       Date:  1998       Impact factor: 21.981

3.  Estrogen replacement therapy and prognosis after first myocardial infarction.

Authors:  K M Newton; A Z LaCroix; B McKnight; R H Knopp; D S Siscovick; S R Heckbert; N S Weiss
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

4.  Risk factors associated with women's compliance with estrogen replacement therapy.

Authors:  R S Berman; R S Epstein; E Lydick
Journal:  J Womens Health       Date:  1997-04       Impact factor: 2.681

5.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

6.  Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta.

Authors:  R Rahimian; I Laher; G Dube; C van Breemen
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

7.  Human vascular smooth muscle cells contain functional estrogen receptor.

Authors:  R H Karas; B L Patterson; M E Mendelsohn
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

8.  Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease.

Authors:  G M Rosano; P M Sarrel; P A Poole-Wilson; P Collins
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

9.  Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

Authors:  A A Nabulsi; A R Folsom; A White; W Patsch; G Heiss; K K Wu; M Szklo
Journal:  N Engl J Med       Date:  1993-04-15       Impact factor: 91.245

10.  Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells.

Authors:  W C Chang; J Nakao; H Orimo; S I Murota
Journal:  Biochim Biophys Acta       Date:  1980-12-05
View more
  2 in total

Review 1.  Pharmacokinetics of selective estrogen receptor modulators.

Authors:  Karla C Morello; Gregory T Wurz; Michael W DeGregorio
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  A review of coumarin derivatives in pharmacotherapy of breast cancer.

Authors:  Musiliyu A Musa; John S Cooperwood; M Omar F Khan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.